Abstract

Pancreatic neuroendocrine tumours (PNET) is a rare disease and in the absence of metastases, surgical resection is recommended. Key factors affecting survival in PNETs are the stage and grade of the disease, but there is increasing evidence suggesting lymph node involvement is associated with shorter disease-free and overall survival. Ability to predict the likelihood of lymph node involvement at the time of diagnosis would affect surgical decision making in these patients. A systemic inflammatory index such as neutrophil to lymphocyte ratio or platelet to lymphocyte ratio has been associated with poor prognosis in several cancers.Method: This study is a retrospective multi-centre study. The data including pre-operative inflammatory markers such as haemoglobin, neutrophil, lymphocyte counts and pathological data including number of positive lymph nodes, tumour grade and size, are collected to assess the association between inflammatory index and lymph node involvement.Conclusion: This study aims to assess the value of routinely available pre-operative haematological markers in predicting lymph node involvement in non-functioning PNETs.

Highlights

  • AND RATIONALE FOR THE STUDYPancreatic neuroendocrine tumour (PNET) is a rare disease and comprises of around 3% of newly diagnosed pancreatic malignancies each year [1]

  • This study aims to assess the value of routinely available pre-operative haematological markers in predicting lymph node involvement in non-functioning Pancreatic neuroendocrine tumours (PNET)

  • Several papers have demonstrated that the key factors affecting survival in PNETs are stage and grade [3,4,5], emerging evidence suggests that lymph node involvement is associated with shorter disease-free and overall survival [6, 7]

Read more

Summary

Conclusion

This study aims to assess the value of routinely available pre-operative haematological markers in predicting lymph node involvement in non-functioning PNETs. Keywords: pancreatic neuroendocrine tumour, inflammatory index, lymph node involvement, disease outcome, survival

BACKGROUND
OBJECTIVES
Study Design
Findings
ETHICS STATEMENT
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call